Rhode Island Hospital receives $1.6M to study opioid treatment and care at pharmacies

RHODE ISLAND HOSPITAL has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care to people with opioid use disorder at pharmacies. / COURTESY LIFESPAN CORP.
RHODE ISLAND HOSPITAL has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care to people with opioid use disorder at pharmacies. / COURTESY LIFESPAN CORP.
PROVIDENCE – Rhode Island Hospital has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care at pharmacies for people with opioid-use disorder, Lifespan Corp. announced Monday The three-year study will be conducted in collaboration with the University of Rhode Island College of Pharmacy, the R.I. Department…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -